Medtronic plc (MDT) Revenue from Contract with Customer, Excluding Assessed Tax USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Medtronic plc quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2016 to 2023.
  • Medtronic plc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending January 26, 2024 was $8.09B, a 4.69% increase year-over-year.
  • Medtronic plc Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending January 26, 2024 was $32.3B, a 5.03% increase year-over-year.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $8.09B +$362M +4.69% Oct 28, 2023 Jan 26, 2024 10-Q 2024-02-27
Q3 2023 $7.98B +$399M +5.26% Jul 29, 2023 Oct 27, 2023 10-Q 2023-11-30
Q2 2023 $7.7B +$331M +4.49% Apr 29, 2023 Jul 28, 2023 10-Q 2023-08-31
Q1 2023 $8.54B +$455M +5.63% Jan 28, 2023 Apr 28, 2023 10-K 2023-06-22
Q1 2022 $31.2B -$459M -1.45% Apr 30, 2022 Apr 28, 2023 10-K 2023-06-22
Q4 2022 $7.73B -$36M -0.46% Oct 29, 2022 Jan 27, 2023 10-Q 2024-02-27
Q3 2022 $7.59B -$262M -3.34% Jul 30, 2022 Oct 28, 2022 10-Q 2023-11-30
Q2 2022 $7.37B -$616M -7.71% Apr 30, 2022 Jul 29, 2022 10-Q 2023-08-31
Q1 2022 $8.09B -$99M -1.21% Jan 29, 2022 Apr 29, 2022 10-K 2023-06-22
Q1 2021 $31.7B +$1.57B +5.21% May 1, 2021 Apr 29, 2022 10-K 2023-06-22
Q4 2021 $7.76B -$12M -0.15% Oct 30, 2021 Jan 28, 2022 10-Q 2023-03-01
Q3 2021 $7.85B +$200M +2.62% Jul 31, 2021 Oct 29, 2021 10-Q 2022-12-01
Q2 2021 $7.99B +$1.48B +22.7% May 1, 2021 Jul 30, 2021 10-Q 2022-09-01
Q1 2021 $8.19B +$2.19B +36.5% Jan 30, 2021 Apr 30, 2021 10-K 2023-06-22
Q1 2020 $30.1B +$1.2B +4.16% Apr 25, 2020 Apr 30, 2021 10-K 2023-06-22
Q4 2020 $7.78B +$58M +0.75% Oct 31, 2020 Jan 29, 2021 10-Q 2022-03-03
Q3 2020 $7.65B -$59M -0.77% Aug 1, 2020 Oct 30, 2020 10-Q 2021-12-02
Q2 2020 $6.51B -$986M -13.2% Apr 25, 2020 Jul 31, 2020 10-Q 2021-09-02
Q1 2020 $6B -$2.15B -26.4% Jan 25, 2020 Apr 24, 2020 10-K 2020-06-19
Q1 2019 $28.9B -$1.64B -5.38% Apr 27, 2019 Apr 24, 2020 10-K 2022-06-23
Q4 2019 $7.72B +$171M +2.27% Oct 26, 2019 Jan 24, 2020 10-Q 2021-03-05
Q3 2019 $7.71B +$225M +3.01% Jul 27, 2019 Oct 25, 2019 10-Q 2020-12-03
Q2 2019 $7.49B +$109M +1.48% Apr 27, 2019 Jul 26, 2019 10-Q 2020-09-03
Q1 2019 $8.15B +$2M +0.03% Jan 26, 2019 Apr 26, 2019 10-K 2020-06-19
Q1 2018 $30.6B +$604M +2.02% Apr 28, 2018 Apr 26, 2019 10-K 2021-06-25
Q4 2018 $7.55B +$177M +2.4% Oct 27, 2018 Jan 25, 2019 10-K 2020-06-19
Q3 2018 $7.48B +$431M +6.11% Jul 28, 2018 Oct 26, 2018 10-K 2020-06-19
Q2 2018 $7.38B -$6M -0.08% Apr 28, 2018 Jul 27, 2018 10-K 2020-06-19
Q1 2018 $8.14B Jan 27, 2018 Apr 27, 2018 10-K 2019-06-21
Q1 2017 $30B +$243M +0.82% Apr 29, 2017 Apr 27, 2018 10-K 2020-06-19
Q4 2017 $7.37B Oct 28, 2017 Jan 26, 2018 10-K 2019-06-21
Q3 2017 $7.05B Jul 29, 2017 Oct 27, 2017 10-K 2019-06-21
Q2 2017 $7.39B Apr 29, 2017 Jul 28, 2017 10-K 2019-06-21
Q1 2016 $29.7B Apr 30, 2016 Apr 28, 2017 10-K 2019-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.